Study links Fragile X Syndrome proteins and RNA editing mistakes at nerve-muscle junction

October 30, 2011
This is a schematic of a neuromuscular junction (NMJ). Credit: Balpreet Bhogal, Perelman School of Medicine, University of Pennsylvania

The most common form of heritable cognitive impairment is Fragile X Syndrome, caused by mutation or malfunction of the FMR1 gene. Loss of FMR1 function is also the most common genetic cause of autism. Understanding how this gene works is vital to finding new treatments to help Fragile X patients and others.

Researchers from the Perelman School of Medicine at the University of Pennsylvania, and colleagues from Brown University, have identified the FMRP protein (encoded by FMR1) as a key player in RNA editing, a process in which the working copies made from DNA, called messenger RNAs, are chemically altered after being transcribed from the genome. Their findings were published online this week in .

Since RNAs are used as the instructions to make proteins, mistakes in RNA editing at the (NMJ), the site at which motor neurons innervate muscle, may cause problems in . Previous work at Penn and several other institutions strongly suggested the role of FMRP to be in regulating the translation of certain types of RNA at the synapse, the space between two nerves, or between nerves and muscles.

"Most of the field has been focused on looking at FMRP interacting with specific RNAs and how it regulates their translation at the synapse," states lead author Thomas A. Jongens, PhD, associate professor of Genetics at Penn. "Here we've tapped into identifying a function that FMRP has in regulating another process called RNA editing that is important in regulating ." In RNA editing, the information encoded by DNA into an RNA molecule is altered, thus affecting the functioning of the proteins encoded by that RNA.

"This work elegantly links the Drosophila to both an RNA-editing pathway and the architecture of the neuromuscular junction synapse," says Donna Kransnewich, PhD, who oversees grants focused on mechanisms of human genetic disorders at the National Institute of General Medical Sciences of the National Institutes of Health. "These exciting findings bring us closer to understanding the molecular basis of , the most common inherited intellectual disability, and highlight the value of basic science research in uncovering the underlying causes of human disorders."

Lords of the Flies

Jongens, Penn colleague Balpreet Bhogal, and Brown colleague Robert Reenan studied the fruit fly, Drosophila, whose genome contains a cousin of the human FMR1 gene called dFMR1. The Jongens lab is one of several that use Drosophila models to study Fragile X Syndrome.

"The Drosophila dFMR1 gene is fairly similar to that in humans at the amino acid level - there's about a 50 percent overall similarity between the two proteins," Jongens notes. "But if you look at specific domains, there are pockets of even higher similarity. That makes us fairly confident that some of what we'll discover from the fly model translates to people."

Flies with mutated dFMR1 genes exhibit similar physiological symptoms as humans with Fragile X, including memory and cognitive deficits, disrupted sleep and circadian rhythms, and impaired social behavior.

Two Key Proteins

Another impaired trait due to the mutation is overgrowth and branching of the neuromuscular junction. The research group showed that another key protein critical for normal functioning and architecture at the NMJ is ADAR (dADAR in Drosophila), which is involved in RNA editing of specific mRNAs. The researchers examined the Drosophila NMJ to determine whether dFMR1 and dADAR interact.

They found that the right amounts of the two proteins are important for proper RNA editing and therefore nerve activity at the nerve-muscle synapse. Using a variety of genetic and molecular analyses, Jongens and colleagues were able to link dFMR1 with dADAR via the RNA editing required for normal NMJ structure.

Observing that flies with dADAR mutations displayed similar NMJ defects to flies with dFMR1 mutations, the team demonstrated that both the dFMR1 and dADAR proteins act in the motor neuron to form the neuromuscular junction, indicating that ADAR is required for proper NMJ structure.

In addition, says Jongens, "we found that ADAR acts downstream of dFMR1, suggesting that dFMR1 is required to maintain the proper activity levels of ADAR in the synapse. The FMR protein physically associates with the fly ADAR protein, and through genetic studies we see that there's a dependence of ADAR function on FMRP. If you don't have FMRP, or if you have too much, the editing efficiency of certain sites on select mRNAs is changed. So we think that FMRP might play a role - through the editing process - in modulating the fine tuning of neuronal activity."

The work is the first study to report a disease-associated protein that interacts with and modulates RNA editing. "It provides another way in which the Fragile X Syndrome animal models can be examined to look for defects in neuronal processes that might explain symptoms seen in people," Jongens explains.

Reenan, professor of Molecular Biology, Cell Biology and Biochemistry at Brown, agrees, saying that the implications of the study could be quite broad: "It is a remarkable finding that FMRP can be linked so directly with ADAR and RNA editing activity. Deranged RNA editing has been implicated in epilepsy, suicidal depression, schizophrenia, and even some neurological cancers. These data are surely pointing in the direction of deep connections between numerous distinct diseases of the brain."

The next step in the research will focus on how the two proteins come together to act on the same RNA targets. "The more we know about what the FMR protein does, the more likely we are to uncover ways to treat disease," Jongens points out.

Explore further: Workings of brain protein suggest therapies for inherited intellectual disability, autism

Related Stories

Workings of brain protein suggest therapies for inherited intellectual disability, autism

July 21, 2011
Researchers now have a much clearer understanding of how mutations in a single gene can produce the complex cognitive deficits characteristic of Fragile X Syndrome, the most common inherited form of intellectual disability. ...

Fragile X protein acts as toggle switch in brain cells

June 9, 2011
New research shows how the protein missing in fragile X syndrome – the most common inherited form of intellectual disability – acts as a molecular toggle switch in brain cells.

New clue found for Fragile X syndrome-epilepsy link

April 12, 2011
Individuals with fragile X syndrome, the most common inherited form of intellectual disability, often develop epilepsy, but so far the underlying causes are unknown. Researchers have now discovered a potential mechanism that ...

Recommended for you

Cognitive cross-training enhances learning, study finds

July 25, 2017
Just as athletes cross-train to improve physical skills, those wanting to enhance cognitive skills can benefit from multiple ways of exercising the brain, according to a comprehensive new study from University of Illinois ...

Brain disease seen in most football players in large report

July 25, 2017
Research on 202 former football players found evidence of a brain disease linked to repeated head blows in nearly all of them, from athletes in the National Football League, college and even high school.

Lutein may counter cognitive aging, study finds

July 25, 2017
Spinach and kale are favorites of those looking to stay physically fit, but they also could keep consumers cognitively fit, according to a new study from University of Illinois researchers.

Zebrafish study reveals clues to healing spinal cord injuries

July 25, 2017
Fresh insights into how zebrafish repair their nerve connections could hold clues to new therapies for people with spinal cord injuries.

Brain stimulation may improve cognitive performance in people with schizophrenia

July 24, 2017
Brain stimulation could be used to treat cognitive deficits frequently associated with schizophrenia, according to a new study from King's College London.

New map may lead to drug development for complex brain disorders, researcher says

July 24, 2017
Just as parents are not the root of all their children's problems, a single gene mutation can't be blamed for complex brain disorders like autism, according to a Keck School of Medicine of USC neuroscientist.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.